Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.00

+8.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (1716)	9/21/2000 11:13:52 PM
From: IRWIN JAMES FRANKEL	Read Replies (1) of 52153

CDIC I was on the CC this morning. It did not add much to the PR. Here are a couple of significant items: - They have introduced improved and proprietary sensors for BioZ (the proprietary nature should increase revenue since clinics were using non-CDIC provisioned sensors) - A questioner asked about cash flow. The answer got to operating cash flow which was said to be $500,000 per month or $1.5 million per quarter. It was not clear but I took it to be a negative cash flow of $1.5 million per quarter. There is a replay number posted on the Yahoo thread but Yahoo is not responding now or I would have retrieved it. I would have liked to ask if when they suggest an addressable market size of $5 billion for BioZ equipment and $800 million per year in associated disposables if they had assumed an increase in procedures due to the radical cost reduction associated with using BioZ vs. PAC. Warning: I bought this thing when PS sucked me in. <G> ij

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next